PreviPharma

Executive Summary

PreviPharma, founded in 2018 and headquartered in Hamburg, Germany, is a private company specializing in plasma fractionation services. The company positions itself as a full-service partner for the pharmaceutical industry, offering tailored solutions across the entire plasma fractionation value chain. With a focus on flexibility and client-specific needs, PreviPharma supports customers from process development to commercial manufacturing. Operating in the oncology and infectious disease categories, the company leverages its expertise to address critical therapeutic areas. Despite being a relatively young company, PreviPharma's commitment to service excellence and its niche focus on plasma fractionation could position it as a valuable partner for biopharma firms seeking reliable and customized manufacturing capabilities. However, due to limited public information on specific pipeline assets or financials, the company's near-term impact remains unclear.